We are live on ! Find out more
Axa

Axa Portfolio holdings

AUM $91.9M
1-Year Est. Return 27.41%
This Fund
S&P 500
This Quarter Est. Return
+3.61%
1 Year Est. Return
+27.41%
3 Year Est. Return
+100.68%
5 Year Est. Return
+129.89%
10 Year Est. Return
+554.73%
AUM
$22B
AUM Growth
-$123M
Cap. Flow
-$1.19B
Cap. Flow %
-5.42%
Top 10 Hldgs %
11.79%
Holding
1,359
New
101
Increased
421
Reduced
517
Closed
125

Top Buys

Rank Stock Value
1
MU icon
Micron Technology
MU
+$62M
2
UBS icon
UBS Group
UBS
+$49.7M
3
APD icon
Air Products & Chemicals
APD
+$47.3M
4
T icon
AT&T
T
+$44.6M
5
LRCX icon
Lam Research
LRCX
+$39.6M

Top Sells

Rank Stock Value
1
HPE icon
Hewlett Packard
HPE
+$61.6M
2
HCA icon
HCA Healthcare
HCA
+$50.8M
3
GEN icon
Gen Digital
GEN
+$50.7M
4
BAX icon
Baxter International
BAX
+$50.6M
5
JNJ icon
Johnson & Johnson
JNJ
+$49.1M

Sector Composition

Rank Sector Weight
1 Technology 17.71%
2 Healthcare 16.86%
3 Financials 11.57%
4 Consumer Discretionary 9.44%
5 Industrials 9.41%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
PNR icon
876
Pentair
PNR
$9.03B
$1.15M 0.01%
25,660
-71,919
-74% -$3.14M
TBRG
877
DELISTED
TruBridge
TBRG
$1.14M 0.01%
34,800
-1,700
-5% -$52.9K
MSF
878
DELISTED
Morgan Stanley Emerging Mkts Fd
MSF
$1.13M 0.01%
70,000
MCRN
879
DELISTED
Milacron Holdings Corp.
MCRN
$1.12M 0.01%
63,800
+10,700
+20% +$192K
MXL icon
880
MaxLinear
MXL
$6.09B
$1.12M 0.01%
40,000
EWU icon
881
iShares MSCI United Kingdom ETF
EWU
$3.71B
$1.11M 0.01%
33,200
RL icon
882
Ralph Lauren
RL
$20B
$1.11M 0.01%
14,981
-111,728
-88% -$8.38M
ICFI icon
883
ICF International
ICFI
$1.59B
$1.09M 0.01%
23,160
-34,440
-60% -$1.57M
LCII icon
884
LCI Industries
LCII
$2.13B
$1.09M 0.01%
10,655
-556
-5% -$53.3K
QLYS icon
885
Qualys
QLYS
$6.41B
$1.09M ﹤0.01%
26,711
+8,022
+43% +$322K
MED icon
886
Medifast
MED
$134M
$1.08M ﹤0.01%
26,000
RF icon
887
Regions Financial
RF
$25.3B
$1.08M ﹤0.01%
73,498
+1,600
+2% +$22.5K
EEMV icon
888
iShares MSCI Emerging Markets Min Vol Factor ETF
EEMV
$3.59B
$1.07M ﹤0.01%
19,410
+400
+2% +$22K
RGP icon
889
Resources Connection
RGP
$144M
$1.06M ﹤0.01%
+77,500
New +$1.05M
EELV icon
890
Invesco S&P Emerging Markets Low Volatility ETF
EELV
$429M
$1.06M ﹤0.01%
44,240
EZPW icon
891
Ezcorp Inc
EZPW
$1.86B
$1.06M ﹤0.01%
137,193
KMX icon
892
CarMax
KMX
$8.49B
$1.05M ﹤0.01%
16,700
+300
+2% +$18.1K
NEWT icon
893
NewtekOne
NEWT
$349M
$1.05M ﹤0.01%
64,600
SYNT
894
DELISTED
Syntel Inc
SYNT
$1.05M ﹤0.01%
+61,700
New +$1.07M
WAL icon
895
Western Alliance Bancorporation
WAL
$8.62B
$1.04M ﹤0.01%
21,100
-8,800
-29% -$419K
CLGX
896
DELISTED
Corelogic, Inc.
CLGX
$1.04M ﹤0.01%
23,900
OKE icon
897
Oneok
OKE
$59.7B
$1.03M ﹤0.01%
19,700
-204,800
-91% -$10.6M
MIDD icon
898
Middleby
MIDD
$5.02B
$1.02M ﹤0.01%
8,424
+100
+1% +$13.2K
PACW
899
DELISTED
PacWest Bancorp
PACW
$1.02M ﹤0.01%
21,890
-12,600
-37% -$615K
WTW icon
900
Willis Towers Watson
WTW
$29.9B
$1.02M ﹤0.01%
7,011
-308,190
-98% -$43.1M

Similar funds

Axa's Q2 2017 Portfolio in Review

As of Q2 2017, Axa held 1,359 positions worth $22B, down 0.55% from $22.1B the previous quarter. Its ten largest holdings account for 12% of the portfolio.

Axa withdrew a net $1.19B in Q2 2017, closing 125 positions and reducing 517 holdings. Its most notable exit was Mead Johnson Nutrition Company, an estimated $22.7M position sold in full.

By sector, the portfolio is most concentrated in Technology at 18% of assets, up from 17% a quarter earlier, followed by Healthcare and Financials.

Against the trend, Axa opened a new position in Element Solutions worth $22.3M.

  • Axa's largest Q2 2017 buy was Element Solutions: 1,758,931 shares worth $22.3M.
  • Axa added most to Micron Technology in Q2 2017, an estimated $62M increase.
  • Axa's biggest Q2 2017 reduction was Hewlett Packard, cutting an estimated $61.6M.
  • Axa fully exited Mead Johnson Nutrition Company in Q2 2017, selling an estimated $22.7M.
  • Axa's ten largest holdings make up 12% of its $22B portfolio in Q2 2017.
  • Axa opened 101 new positions and closed 125 in Q2 2017.
  • Axa's portfolio value fell 0.55% quarter-over-quarter to $22B.

Based on Axa's 13F filing for Q2 2017, filed 10 Aug 2017.